Development of Humanized Mouse Models for Studying Human NK Cells in Health and Disease

Overview

Journal Methods Mol Biol

Specialty Molecular Biology

Date 2022 Mar 28

PMID 35344167

Authors

Liang Shan

Richard A Flavell

Dietmar Herndler-Brandstetter

Affiliations

Soon will be listed here.

Abstract

Humanized mice, which we define as immunodeficient mice that have been reconstituted with a human immune system, represent promising preclinical models for translational research and precision medicine as they allow modeling and therapy of human diseases in vivo. The first generation of humanized mice showed insufficient development, diversity and function of human immune cells, in particular human natural killer (NK) cells and type 1 innate lymphoid cells (ILC1). This limited the applicability of humanized mice for studying ILC1 and NK cells in the context of human cancers and immunotherapeutic manipulation. However, since 2014, several next-generation humanized mouse models have been developed that express human IL-15 either as a transgene or knock-in (NOG-IL15, NSG-IL15, NSG-IL7-IL15, SRG-15) or show improved development of human myeloid cells, which express human IL-15 and thereby promote human NK cell development (NSG-SGM3, MISTRG, BRGSF). Here we compare the various next-generation humanized mouse models and describe the methodological procedures for creating mice with a functioning human immune system and how they can be used to study and manipulate human NK cells in health and disease.

Citing Articles

PBMC-engrafted humanized mice models for evaluating immune-related and anticancer drug delivery systems.

Kametani Y, Ito R, Manabe Y, Kulski J, Seki T, Ishimoto H Front Mol Biosci. 2024; 11:1447315.

PMID: 39228913 PMC: 11368775. DOI: 10.3389/fmolb.2024.1447315.

Psoriatic arthritis subtypes are phenocopied in humanized mice.

Ritchlin C, Rangel-Moreno J, Martino D, Isett B, Paine A, Bhattacharya S JCI Insight. 2024; 9(15).

PMID: 39114979 PMC: 11383598. DOI: 10.1172/jci.insight.178213.

Examining Chronic Inflammation, Immune Metabolism, and T Cell Dysfunction in HIV Infection.

Mu W, Patankar V, Kitchen S, Zhen A Viruses. 2024; 16(2).

PMID: 38399994 PMC: 10893210. DOI: 10.3390/v16020219.

deletion mutant protects hosts against infection and breast tumors.

Chen M, Yang P, Xin Z, Chen J, Zou W, Zhou L Front Immunol. 2023; 14:1173379.

PMID: 37426671 PMC: 10327641. DOI: 10.3389/fimmu.2023.1173379.

Murine models to study human NK cells in human solid tumors.

Parodi M, Astigiano S, Carrega P, Pietra G, Vitale C, Damele L Front Immunol. 2023; 14:1209237.

PMID: 37388731 PMC: 10301748. DOI: 10.3389/fimmu.2023.1209237.

References

Wunderlich M, Chou F, Sexton C, Presicce P, Chougnet C, Aliberti J . Improved multilineage human hematopoietic reconstitution and function in NSGS mice. PLoS One. 2018; 13(12):e0209034. PMC: 6291127. DOI: 10.1371/journal.pone.0209034. View

Matsuda M, Ono R, Iyoda T, Endo T, Iwasaki M, Tomizawa-Murasawa M . Human NK cell development in hIL-7 and hIL-15 knockin NOD/SCID/IL2rgKO mice. Life Sci Alliance. 2019; 2(2). PMC: 6445396. DOI: 10.26508/lsa.201800195. View

Rongvaux A, Willinger T, Martinek J, Strowig T, Gearty S, Teichmann L . Development and function of human innate immune cells in a humanized mouse model. Nat Biotechnol. 2014; 32(4):364-72. PMC: 4017589. DOI: 10.1038/nbt.2858. View

Spits H, Artis D, Colonna M, Diefenbach A, Di Santo J, Eberl G . Innate lymphoid cells--a proposal for uniform nomenclature. Nat Rev Immunol. 2013; 13(2):145-9. DOI: 10.1038/nri3365. View

Katano I, Takahashi T, Ito R, Kamisako T, Mizusawa T, Ka Y . Predominant development of mature and functional human NK cells in a novel human IL-2-producing transgenic NOG mouse. J Immunol. 2015; 194(7):3513-25. DOI: 10.4049/jimmunol.1401323. View

Ishikawa F, Yasukawa M, Lyons B, Yoshida S, Miyamoto T, Yoshimoto G . Development of functional human blood and immune systems in NOD/SCID/IL2 receptor {gamma} chain(null) mice. Blood. 2005; 106(5):1565-73. PMC: 1895228. DOI: 10.1182/blood-2005-02-0516. View

Song Y, Gbyli R, Fu X, Halene S . Functional Analysis of Human Hematopoietic Stem Cells In Vivo in Humanized Mice. Methods Mol Biol. 2019; 2097:273-289. DOI: 10.1007/978-1-0716-0203-4_18. View

Sippel T, Radtke S, Olsen T, Kiem H, Rongvaux A . Human hematopoietic stem cell maintenance and myeloid cell development in next-generation humanized mouse models. Blood Adv. 2019; 3(3):268-274. PMC: 6373748. DOI: 10.1182/bloodadvances.2018023887. View

Koskinen C, Persson E, Baldock P, Stenberg A, Bostrom I, Matozaki T . Lack of CD47 impairs bone cell differentiation and results in an osteopenic phenotype in vivo due to impaired signal regulatory protein α (SIRPα) signaling. J Biol Chem. 2013; 288(41):29333-44. PMC: 3795235. DOI: 10.1074/jbc.M113.494591. View

10.

Chiossone L, Dumas P, Vienne M, Vivier E . Natural killer cells and other innate lymphoid cells in cancer. Nat Rev Immunol. 2018; 18(11):671-688. DOI: 10.1038/s41577-018-0061-z. View

11.

Kennedy M, Glaccum M, Brown S, Butz E, Viney J, Embers M . Reversible defects in natural killer and memory CD8 T cell lineages in interleukin 15-deficient mice. J Exp Med. 2000; 191(5):771-80. PMC: 2195858. DOI: 10.1084/jem.191.5.771. View

12.

Lopez-Lastra S, Masse-Ranson G, Fiquet O, Darche S, Serafini N, Li Y . A functional DC cross talk promotes human ILC homeostasis in humanized mice. Blood Adv. 2018; 1(10):601-614. PMC: 5728352. DOI: 10.1182/bloodadvances.2017004358. View

13.

Bjorkstrom N, Ljunggren H, Michaelsson J . Emerging insights into natural killer cells in human peripheral tissues. Nat Rev Immunol. 2016; 16(5):310-20. DOI: 10.1038/nri.2016.34. View

14.

Gao Y, Souza-Fonseca-Guimaraes F, Bald T, Ng S, Young A, Ngiow S . Tumor immunoevasion by the conversion of effector NK cells into type 1 innate lymphoid cells. Nat Immunol. 2017; 18(9):1004-1015. DOI: 10.1038/ni.3800. View

15.

Herndler-Brandstetter D, Shan L, Yao Y, Stecher C, Plajer V, Lietzenmayer M . Humanized mouse model supports development, function, and tissue residency of human natural killer cells. Proc Natl Acad Sci U S A. 2017; 114(45):E9626-E9634. PMC: 5692533. DOI: 10.1073/pnas.1705301114. View

16.

Katano I, Nishime C, Ito R, Kamisako T, Mizusawa T, Ka Y . Long-term maintenance of peripheral blood derived human NK cells in a novel human IL-15- transgenic NOG mouse. Sci Rep. 2017; 7(1):17230. PMC: 5722902. DOI: 10.1038/s41598-017-17442-7. View

17.

Rongvaux A, Takizawa H, Strowig T, Willinger T, Eynon E, Flavell R . Human hemato-lymphoid system mice: current use and future potential for medicine. Annu Rev Immunol. 2013; 31:635-674. PMC: 4120191. DOI: 10.1146/annurev-immunol-032712-095921. View

18.

Yao L, Aryee K, Cheng M, Kaur P, Keck J, Brehm M . Creation of PDX-Bearing Humanized Mice to Study Immuno-oncology. Methods Mol Biol. 2019; 1953:241-252. DOI: 10.1007/978-1-4939-9145-7_15. View